Clinical Study for the Efficacy and Safety of Ropeginterferon Alfa-2b in Adult COVID-19 Patients With Comorbidities
Clinical trial NCT05808322 · UNKNOWN
Trial details
- NCT number
- NCT05808322
- Sponsor
- National Taiwan University Hospital
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-15
- Primary completion
- 2024-05-16
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.